Cancer Cell Discrimination and Dynamic Viability Monitoring Through Wash-Free Bioimaging Using AIEgens.

Ruoyao Zhang,Guangle Niu,Qing Lu,Xiaolin Huang,Joe H. C. Chau,Ryan T. K. Kwok,Xiaoqiang Yu,Min-Hui Li,Jacky W. Y. Lam,Ben Zhong Tang

DOI: https://doi.org/10.1039/d0sc01213k

IF: 8.4

2020-01-01

Chemical Science

Abstract:We present a series of AIEgens for cancer cell discrimination and dynamic viability monitoring.

What problem does this paper attempt to address?

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

Yuxiang Pan,Yong Qiu,Deming Jiang,Xin Liu,Chenlei Gu,Hao Wan,Ping Wang

DOI: https://doi.org/10.1109/nanomed49242.2019.9130615

2019-01-01

Abstract:Drug screening is traditionally based on the pharmacodynamic models from 2D cell culture or animal experiments. Recently, three-dimensional (3D) tumor cell models have attracted increasing interest due to their great advantages in simulating more accurately the heterogeneous tumor behavior in vivo. Drug screening based on 3D cells can provide more accurate efficacy results. However, it is difficult to realize real-time and label-free monitoring of 3D cell viability by common imaging techniques. To solve this technical difficulty, a novel micro-groove impedance sensor (MGIS) was specially developed for 3D cell viability real-time monitoring. Precultured 3D spheroids cells are trapped in the micro-cavity with opposite gold electrodes for the in-situ impedance measurement. The presence of 3D spheroid cells will lead to the change of electron transfer efficiency on the electrode surface, which will lead to the change of impedance. When antitumor drugs act on the spheroid cells, the spheroids will cleave and the impedance will decrease. In order to verify the accuracy of MGIS chip, we adopted standard live/dead fluorescence staining to validate the activity of 3D cells. Furthermore, anti-tumor drug sensitivity tests were conducted to validate the drug screening ability of MGIS plat-form. All the results demonstrate that the MGIS is able to monitoring 3D cell viability and drug screening.
Wash-free detection and bioimaging by AIEgens

Xiaolin Huang,Ruoyao Zhang,Chao Chen,Ryan T. K. Kwok,Ben Zhong Tang

DOI: https://doi.org/10.1039/d0qm00586j

IF: 8.6834

2021-01-01

Materials Chemistry Frontiers

Abstract:Herein, the latest progress of AIEgens for application in wash-free detection and bioimaging was reviewed.

materials science, multidisciplinary,chemistry
Micro-electrode cell-based biosensor using electrochemical impedance spectroscopy for cancer research

Qingjun Lìu,Jinjiang Yu,Hui Yu,Lidan Xiao,Pinǵ Wang,Mo Yang

DOI: https://doi.org/10.1007/978-3-540-79039-6_78

2008-01-01

Abstract:In this study, cell biosensor chip with micro-electrode arrays was used to monitor the culture behaviour of mammalian cancer cells and evaluate the chemosensitivity of anti-cancer drugs using electrochemical impedance spectroscopy. The electrode arrays were fabricated by semiconductor technology with diameter from 50 pm to 10 pm of each electrode. The human oesophageal cancer cell lines (KYSE 30) were cultured on the surface of the electrode with the help of fibronectin. Morphology changes of cells adhesion, spreading, and proliferation can be detected by impedimetric analysis in a real time and non-invasive way. Anti-caner drug of cisplatin was added to cells for potential drug screening applications. The experimental results show that drug's chemosensitivity effects can be detected by this cell based biosensor.
3D Microgroove Electrical Impedance Sensing to Examine 3D Cell Cultures for Antineoplastic Drug Assessment

Yuxiang Pan,Deming Jiang,Chenlei Gu,Yong Qiu,Hao Wan,Ping Wang

DOI: https://doi.org/10.1038/s41378-020-0130-x

2020-01-01

Microsystems & Nanoengineering

Abstract:In recent decades, three-dimensional (3D) cancer cell models have attracted increasing interest in the field of drug screening due to their significant advantages in more accurate simulations of heterogeneous tumor behavior in vivo compared to two-dimensional models. Furthermore, drug sensitivity testing based on 3D cancer cell models can provide more reliable in vivo efficacy prediction. The gold standard fluorescence staining is hard to achieve real-time and label-free viability monitoring in 3D cancer cell models. In this study, a microgroove impedance sensor (MGIS) was specially developed for the dynamic and noninvasive monitoring of 3D cell viability. 3D cancer cells were trapped in microgrooves with gold electrodes on opposite walls for in situ impedance measurement. The change in the number of live cells caused inversely proportional changes to the impedance magnitude of the entire cell/Matrigel construct and reflected the proliferation and apoptosis of the 3D cells. It was confirmed that the 3D cell viability detected by the MGIS was highly consistent with the standard live/dead staining by confocal microscope characterization. Furthermore, the accuracy of the MGIS was validated quantitatively using a 3D lung cancer model and sophisticated drug sensitivity testing. In addition, the parameters of the MGIS in the measurement experiments were optimized in detail using simulations and experimental validation. The results demonstrated that the MGIS coupled with 3D cell culture would be a promising platform to improve the efficiency and accuracy of cell-based anticancer drug screening in vitro.
Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Peili Cen,Jiani Huang,Chentao Jin,Jing Wang,Yen Wei,Hong Zhang,Mei Tian

DOI: https://doi.org/10.1002/agt2.352

2023-01-01

Aggregate

Abstract:Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents in cancers, due to the advantages of large Stokes shift, high quantum yield, great biocompatibility, and strong photostability. AIEgens can specifically target different types of cancer via diverse targeting strategies. AIEgen‐based fluorescence imaging, especially near‐infrared imaging, demonstrated deep penetration and suitable signal‐to‐noise ratio, which allows reliable in vivo cancer imaging. Combined with other imaging modalities, AIEgen‐based multimodal imaging could provide multidimensional cancer hallmarks from different perspectives. In addition, AIEgen‐based phototherapy can be used for photodynamic therapy and photothermal therapy, which facilitate ablation of cancer cells with good biosafety and high therapeutic effects in vivo. AIEgens nanoparticles fabricated with some specific chemicals, drugs, or siRNA, could display synergistic therapeutic effects for cancers. This paper comprehensively describes the current status and future perspectives of AIEgens, which have showed a great potential for the future preclinical and clinical translation on in vivo molecular imaging and theranostics in cancer.
AIEgen-deep: Deep learning of single AIEgen-imaging pattern for cancer cell discrimination and preclinical diagnosis

Haojun Hua,Yanlin Deng,Jing Zhang,Xiang Zhou,Tianfu Zhang,Bee Luan Khoo

DOI: https://doi.org/10.1016/j.bios.2024.116086

IF: 12.545

2024-02-01

Biosensors and Bioelectronics

Abstract:This study introduces AIEgen-Deep, an innovative classification program combining AIEgen fluorescent dyes, deep learning algorithms, and the Segment Anything Model (SAM) for accurate cancer cell identification. Our approach significantly reduces manual annotation efforts by 80%-90%. AIEgen-Deep demonstrates remarkable accuracy in recognizing cancer cell morphology, achieving a 75.9% accuracy rate across 26,693 images of eight different cell types. In binary classifications of healthy versus cancerous cells, it shows enhanced performance with an accuracy of 88.3% and a recall rate of 79.9%. The model effectively distinguishes between healthy cells (fibroblast and WBC) and various cancer cells (breast, bladder, and mesothelial), with accuracies of 89.0%, 88.6%, and 83.1%, respectively. Our method's broad applicability across different cancer types is anticipated to significantly contribute to early cancer detection and improve patient survival rates.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
A Mitochondria-targeted AIEgen Labelled with <SUP>18</SUP>F for Breast Cancer Cell Imaging and Therapy

Kaiwu Yu,Rui Zhou,Yangyang Xu,Yan Zhong,Shufang Qian,Honghai Zhang,Haibin Shi,Qinggang He,Zhengwei Mao,Haoke Zhang,Yen Wei,Hong Zhang,Mei Tian

DOI: https://doi.org/10.1002/asia.202101029

2021-01-01

Chemistry - An Asian Journal

Abstract:A lack of efficient diagnostic tools for early and noninvasive diagnosis of breast cancer has restricted the clinical treatment effect. This problem might be addressed by the combination of aggregation-induced emission (AIE) fluorescence imaging and positron emission tomography (PET) with the dual advantages of high resolution and easy operation, and unlimited penetration and high sensitivity. Here, a mitochondria-targeted AIE luminogen (AIEgen) radiolabeled with F-18 was developed through a two-step radiochemical reaction by virtue of a prosthetic group. The obtained F-18/19-Bz-CP imaging probe was examined by in vitro cell uptake and cell proliferation inhibition in two breast cancer cell lines, showing that the probe can efficiently target and locate in the mitochondria through the analysis of fluorescence imaging and PET simultaneously. Additionally, the probe can induce cancer cell apoptosis with the half maximal inhibitory concentration (IC50) of 4.8 mu M for MCF-7 cells and 7.2 mu M for T47D cells, indicating its potential application for breast cancer therapy.
Three birds with one stone: a single AIEgen for dual-organelle imaging, cell viability evaluation and photodynamic cancer cell ablation

Yuewei Zhang,Shuohang Wang,Ning Zhang,Xiaodong Wang,Qi Zan,Li Fan,Xue Yu,Shaomin Shuang,Chuan Dong

DOI: https://doi.org/10.1039/d1qm01270c

IF: 8.6834

2022-01-01

Materials Chemistry Frontiers

Abstract:We report the first single AIEgen that has great potential for dual-imaging of mitochondria/LDs, detection of cell viability and simultaneously photodynamic ablation of cancer cells.

materials science, multidisciplinary,chemistry
Redox-responsive Fluorescent AIE Bioconjugate with Aggregation Enhanced Retention Features for Targeted Imaging Reinforcement and Selective Suppression of Cancer Cells

Ling Yang,Wen Fang,Yuxiao Ye,Zhengke Wang,Qiaoling Hu,Ben Zhong Tang

DOI: https://doi.org/10.1039/c9qm00216b

IF: 8.6834

2019-01-01

Materials Chemistry Frontiers

Abstract:Redox-responsive fluorescent AIE bioconjugate with aggregation enhanced retention features for targeted imaging reinforcement and selective suppression of cancer cells.
In Vitro Anticancer Activity of AIEgens.

Feng Yin,Bobo Gu,Jingxu Li,Nishtha Panwar,Yong Liu,Zigang Li,Ken-Tye Yong,Ben Zhong Tang

DOI: https://doi.org/10.1039/c9bm00881k

2019-01-01

Biomaterials Science

Abstract:Fluorogens with aggregation-induced emission (AIE) characteristics (AIEgens) possess unique optical properties, design flexibility, and multi-functional capabilities and have established their niche as smart materials since their discovery in 2001. In recent years, AIEgens have found varied applications in sensing, imaging, and therapy in biomedical research. In this work, we systematically and comprehensively investigate the in vitro anticancer activity of AIEgens. We report the high cytotoxicity of AIEgens against cancer cells, especially against cancer stem cells (CSCs) which show high resistance to existing therapeutic drug regimens. Furthermore, we explore the role of AIEgens as novel image-guided chemotherapy agents that offer a new avenue for efficient cancer treatment.
Recent advances in AIE-based platforms for cancer immunotherapy

Ziyi Chen,Xueping Li,Qian Liu,Wen Li,Tianjiao Wang,Dan Ding

DOI: https://doi.org/10.1016/j.jconrel.2024.09.041

IF: 11.467

2024-10-06

Journal of Controlled Release

Abstract:Aggregation-induced emission luminogens (AIEgens) possess the unique property of enhanced fluorescence and photostability in aggregated states, making them exceptional materials for the convergence of imaging and phototherapy. With their inherent advantages, AIEgens are propelling the field of nanomedicine into a vibrant frontier in the phototheranostics of a spectrum of diseases, particularly in the realm of cancer immunotherapy. AIEgens-based therapeutics enhance the cancer immune response through a variety of approaches, including real-time image-guided precise therapy, induction of programmed cell death, metabolic reprogramming, and modulation of the tumor microenvironment. Additionally, they contribute to the synergistic effect of immune checkpoint inhibition, a pivotal aspect of modern cancer immunotherapy strategies. This review offers a comprehensive overview of the integration of AIEgens in nanomedicine and their role in immune adaptation, highlighting the advantages, basic action mechanisms, and recent advancement of AIEgens as promising therapeutic platform for cancer immunotherapy.

pharmacology & pharmacy,chemistry, multidisciplinary
Exploration of Biocompatible AIEgens from Natural Resources

Yuan Gu,Zheng Zhao,Huifang Su,Pengfei Zhang,Junkai Liu,Guangle Niu,Shiwu Li,Zhaoyang Wang,Ryan T K Kwok,Xin-Long Ni,Jingzhi Sun,Anjun Qin,Jacky W Y Lam,Ben Zhong Tang

DOI: https://doi.org/10.1039/c8sc01635f

IF: 8.4

2018-01-01

Chemical Science

Abstract:Luminogens with aggregation-induced emission (AIEgens) characteristics have been well developed and applied in various areas such as bio-imaging, theranostics, organic photoelectronics and chemo/bio sensors. However, most of the reported AIEgens suffer from the disadvantages of complex organic synthesis and high cost, as well as being environmentally unfriendly and hard to degrade, which have largely limited their real applications. In this work, we discovered berberine chloride, a natural isoquinoline alkaloid isolated from Chinese herbal plants, as an unconventional rotor-free AIEgen with bright solid-state emission and water-soluble characteristics. Single crystal structure analysis and optical property, viscosity, and host-guest interaction studies suggested that intramolecular vibration and twisted intramolecular charge transfer were responsible for the AIE phenomenon of berberine chloride. Moreover, berberine chloride was biocompatible and could specifically target lipid droplets in a fluorescence turn-on and wash-free manner, demonstrating the great potential of natural products as promising AIE probes.
Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Shizhen Geng,Pengke Guo,Jing Wang,Yunya Zhang,Yaru Shi,Xinling Li,Mengnian Cao,Yutong Song,Hongling Zhang,Zhenzhong Zhang,Kaixiang Zhang,Haiwei Song,Jinjin Shi,Junjie Liu

DOI: https://doi.org/10.1002/adma.202307923

IF: 29.4

2024-01-01

Advanced Materials

Abstract:In vivo optical imaging of trace biomarkers in residual microtumors holds significant promise for cancer prognosis but poses a formidable challenge. Here, a novel hydrogel sensor is designed for ultrasensitive and specific imaging of the elusive biomarker. This hydrogel sensor seamlessly integrates a molecular beacon nanoprobe with fibroblasts, offering both high tissue retention capability and an impressive signal-to-noise ratio for imaging. Signal amplification is accomplished through exonuclease I-mediated biomarker recycling. The resulting hydrogel sensor sensitively detects the biomarker carcinoembryonic antigen with a detection limit of 1.8 pg mL-1 in test tubes. Moreover, it successfully identifies residual cancer nodules with a median diameter of less than 2 mm in mice bearing partially removed primary triple-negative breast carcinomas (4T1). Notably, this hydrogel sensor is proven effective for the sensitive diagnosis of invasive tumors in post-surgical mice with infiltrating 4T1 cells, leveraging the role of fibroblasts in locally enriching tumor cells. Furthermore, the residual microtumor is rapidly photothermal ablation by polydopamine-based nanoprobe under the guidance of visualization, achieving approximate to 100% suppression of tumor recurrence and lung metastasis. This work offers a promising alternative strategy for visually detecting residual microtumors, potentially enhancing the prognosis of cancer patients following surgical interventions. A postoperative implantable hydrogel sensor integrating a molecular beacon (MB) nanoprobe and fibroblasts is designed for visual detection and elimination of residual microtumors by ultrasensitive in situ monitoring of trace biomarkers, whose amplification of the signal is achieved by fibroblast-mediated local enrichment of tumor cells and spatially selective release of exonuclease I (exo I)-triggered biomarker recycling.image
Aggregation-induced Emission Luminogen for Specific Identification of Malignant Tumour in Vivo

Jianlei Shen,Kun Tao,Peilin Gu,Chen Gui,Dong Wang,Zhenyu Tan,Lihua Wang,Zhiming Wang,Anjun Qin,Ben Zhong Tang,Shisan Bao

DOI: https://doi.org/10.1007/s11426-019-9677-7

2020-01-01

Science China Chemistry

Abstract:Colorectal cancer (CRC) is still a major killer, mainly due to the lack of early detection biomarker with sensitivity/specificity. Conventional histopathology is the gold standard approach in practice, but there are still some issues (false diagnosis and long waiting period). Aggregation-induced emission (AIE) is a novel photophysical phenomenon which has been widely utilized for biological imaging in vivo, including malignant cells, showing remarkable imaging contrast and enhanced emission in high concentrated state. However, it is unclear if AIE dyes can identify malignant cells specifically in vivo. A great challenge for specific labeling of malignant cells is probably ascribed to the complex compositions in tumor tissues. Herein, an AIE dye-based mitochondria-targeted histological staining strategy was employed to localize cancer and the metastatic track in the fresh colorectal cancer. This novel approach holds great potential to revolutionize the clinical diagnosis and intervention for devastating malignancy.
Cellular organelle-targeted smart AIEgens in tumor detection, imaging and therapeutics

Guang Hong Luo,Tian Zhao Xu,Xing Li,Wei Jiang,Yan Hong Duo,Ben Zhong Tang

DOI: https://doi.org/10.1016/j.ccr.2022.214508

IF: 24.833

2022-07-01

Coordination Chemistry Reviews

Abstract:The cell contains various organelles that perform different functions using different biological processes to form a complete organic architecture. Healthy cells and tumor cells often show clear differences in cellular homeostasis. Specific detection, imaging, and therapeutic strategies targeting organelles have been found to be effective for tumor diagnosis and therapy. The multiple functions of AIEgens make them attractive over other nanomaterials, and the application of AIEgens has increased dramatically in tumor-related nanomedicine, specifically, for the detection, bioimaging, and therapy of cancers. Here, recent advances in AIEgen applications targeting specific organelles are summarized. The ability of AIEgens to target specific organelles has enhanced various diagnostic and therapeutic applications of this technology, and this review will provide guidance for further exploration in AIEgen-related nanomedicine.

chemistry, inorganic & nuclear
Visualizing intracellular dynamics with AIE probes

Michelle M. S. Lee,Eric Y. Yu,Ryan T. K. Kwok,Dong Wang,Joe H. C. Chau,Jacky Wing Yip Lam,Ben-Zhong Tang

DOI: https://doi.org/10.1039/d2qm01382g

IF: 8.6834

2023-03-22

Materials Chemistry Frontiers

Abstract:As a sensitive, selective, and non-invasive method, fluorescence bioimaging stands out in biological and pathological studies to visualize biological processes on a microscale. However, the initial photophysical property of conventional organic fluorophores leads to poor photostability and low signal-to-noise ratio, which largely hinder their performance in the long-term monitoring and tracing of intracellular process. In contrast, AIE luminogens (AIEgens) exhibit the opposite photophysical property that overcomes the barrier to facilitate real-time and long-term intracellular dynamics visualization. This work summarizes the recent development of AIE probes to unveil intracellular processes, covering from intracellular microenvironment monitoring to tracing intracellular bioprocess. As fluorescent bioprobes with AIE features depict unlimited potential in bioimaging studies, we hope this review can offer more inspiration and directions to the future design and development of AIEgens for visualizing and monitoring diversified intracellular dynamics.

materials science, multidisciplinary,chemistry
On-chip selective capture of cancer cells and ultrasensitive fluorescence detection of survivin mRNA in a single living cell.

Xiang-Ling Li,Shu Shan,Meng Xiong,Xing-Hua Xia,Jing-juan Xu,Hong-Yuan Chen

DOI: https://doi.org/10.1039/c3lc50587a

IF: 7.517

2013-01-01

Lab on a Chip

Abstract:The rapid recognition of cancer cells and detection of tumor biomarker survivin mRNA plays a critical role in the early diagnosis of many cancers. Based on the integration of specific cancer cell capture and intracellular survivin mRNA detection, this work presents a novel and sensitive on-chip approach for the bioanalysis of survivin mRNA in a single living cell. The microchannel surface was firstly modified with a prostate stem cell antigen (PSCA) monoclonal antibody as the recognition element for prostate cancer cells (PC-3). As a result of the antigen-antibody specific affinity interactions, PC-3 cells could be selectively captured on the microchannel surface. After cell capture, nano-sized graphene oxide-poly(ethylene glycol) bis(amine) (NGO-PEG) was employed as a quencher and carrier of a signal tag, fluorescein isothiocyanate (FITC)-labeled antisense oligonucleotide (F-S1), which is complementary to part of survivin mRNA (target survivin mRNA), to transfect into the captured PC-3 cells. Upon the selective binding of S1 to intracellular survivin mRNA, F-S1 will be released from the NGO-PEG, inducing the fluorescence recovery of FITC. This antibody-based microfluidic device enables simple and inexpensive monitoring of the amount of survivin mRNA in single captured cell without the need for sample pretreatment. The survivin mRNA content in each PC-3 cell was estimated to be (4.8 ± 1.8) × 10(6) copies. This strategy opens a different perspective for ultrasensitive survivin mRNA detection, which may facilitate the early screening for malignancy.
Fabricated AIE-Based Probe to Detect the Resistance to Anoikis of Cancer Cells Detached from Tumor Tissue

Ya-Nan Chang,Yuelan Liang,Jiayi Wang,Ziteng Chen,Ruyu Yan,Kui Chen,Juan Li,Jiacheng Li,Haojun Liang,Gengmei Xing

DOI: https://doi.org/10.3390/cells11213478

IF: 6

2022-11-03

Cells

Abstract:(1) Background: Resisting anoikis is a vital and necessary characteristic of malignant cancer cells, but there is no existing quantification method. Herein, a sensitive probe for assessing anoikis resistance of cancer cells detached from the extracellular matrix was developed based on the aggregation-induced emission (AIE) of AIEgens. It has been reported that detached cancer cell endocytose activated integrin clusters, and in the endosome these clusters recruit and activate phosphorylate focal adhesion kinase (pFAK) in the cytoplasm to induce signaling that supports the growth of detached cancer cells. (2) Methods: We established a lost nest cell model of cancer cells and determined their ability to resist anoikis. The colocalization of the activated integrin, pFAK, and endosomes in model cells was observed and calculated. (3) Results: The fluorescence signal intensity of the probe was significantly higher than that of the integrin antibody in the model cells and the fluorescence signal of probe signal was better overlapped with labeled pFAK by fluorescence in endosomes in model cells. (4) Conclusions: We developed a quantitative multi-parametric image analysis program to calculate fluorescent intensity of the probe and antibodies against pFAK and Rab5 in the areas of colocalization. A positive correlation of fluorescence signal intensity between the probe and pFAK on the endosome was observed. Therefore, the probe was used to quantitatively evaluate resisting anoikis of different cancer cell lines under the lost nest condition.

cell biology
Quantification of Cell Viability and Rapid Screening Anti-Cancer Drug Utilizing Nanomechanical Fluctuation.

Shangquan Wu,Xiaoli Liu,Xiarong Zhou,Xin M. Liang,Dayong Gao,Hong Liu,Gang Zhao,Qingchuan Zhang,Xiaoping Wu

DOI: https://doi.org/10.1016/j.bios.2015.09.024

2016-01-01

Abstract:Cancer is a serious threat to human health. Although numerous anti-cancer drugs are available clinically, many have shown toxic side effects due to poor tumor-selectivity, and reduced effectiveness due to cancers rapid development of resistance to treatment. The development of new highly efficient and practical methods to quantify cell viability and its change under drug treatment is thus of significant importance in both understanding of anti-cancer mechanism and anti-cancer drug screening. Here, we present an approach of utilizing a nanomechanical fluctuation based highly sensitive microcantilever sensor, which is capable of characterizing the viability of cells and quantitatively screening (within tens of minutes) their responses to a drug with the obvious advantages of a rapid, label-free, quantitative, noninvasive, real-time and in-situ assay. The microcantilever sensor operated in fluctuation mode was used in evaluating the paclitaxel effectiveness on breast cancer cell line MCF-7. This study demonstrated that the nanomechanical fluctuations of the microcantilever sensor are sensitive enough to detect the dynamic variation in cellular force which is provided by the cytoskeleton, using cell metabolism as its energy source, and the dynamic instability of microtubules plays an important role in the generation of the force. We propose that cell viability consists of two parts: biological viability and mechanical viability. Our experimental results suggest that paclitaxel has little effect on biological viability, but has a significant effect on mechanical viability. This new method provides a new concept and strategy for the evaluation of cell viability and the screening of anti-cancer drugs.
ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA

Ke Wang,Xiaogang Lin,Maoxiao Zhang,Mengjie Yang,Xiang Shi,Mingna Xie,Yang Luo

DOI: https://doi.org/10.3390/s24020547

IF: 3.9

2024-01-16

Sensors

Abstract:Circulating tumor DNA (ctDNA) appears as a valuable liquid biopsy biomarker in the early diagnosis, treatment, and prognosis of cancer. Here, a biosensing method derived from the AC electrokinetics (ACEK) effect was constructed in this study for the simple, efficient, and rapid method of detection of ctDNA. In the proof-of-concept experiment, ctDNA from the PIK3CA E542K mutant in breast cancer was quantified by detecting a normalized capacitance change rate using a forked-finger gold electrode as the sensing electrode in combination with the ACEK effect. We compared two formats for the construction of the approach by employing varied immobilization strategies; one is to immobilize the DNA capture probe on the electrode surface by Au–S bonding, while the other immobilizes the probe on a self-assembled membrane on the electrode surface by amide bonding. Both formats demonstrated ultrafast detection speed by completing the ctDNA quantification within 1 min and a linear range of 10 fM–10 pM was observed. Meanwhile, the immobilization via the self-assembled membrane yielded improved stability, sensitivity, and specificity than its Au–S bonding counterpart. A detection limit of 1.94 fM was eventually achieved using the optimized approach. This research provides a label-free and minute-scale universal method for the detection of various malignant tumors. The ctDNA biosensors based on the ACEK effect improved according to the probe type or electrode structure and have potential applications in tumor drug efficacy prediction, drug resistance monitoring, screening of high-risk groups, differential diagnosis, monitoring of tiny residual lesions, and prognosis determination.

engineering, electrical & electronic,chemistry, analytical,instruments & instrumentation

Cancer Cell Discrimination and Dynamic Viability Monitoring Through Wash-Free Bioimaging Using AIEgens.

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

Wash-free detection and bioimaging by AIEgens

Micro-electrode cell-based biosensor using electrochemical impedance spectroscopy for cancer research

3D Microgroove Electrical Impedance Sensing to Examine 3D Cell Cultures for Antineoplastic Drug Assessment

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

AIEgen-deep: Deep learning of single AIEgen-imaging pattern for cancer cell discrimination and preclinical diagnosis

A Mitochondria-targeted AIEgen Labelled with <SUP>18</SUP>F for Breast Cancer Cell Imaging and Therapy

Three birds with one stone: a single AIEgen for dual-organelle imaging, cell viability evaluation and photodynamic cancer cell ablation

Redox-responsive Fluorescent AIE Bioconjugate with Aggregation Enhanced Retention Features for Targeted Imaging Reinforcement and Selective Suppression of Cancer Cells

In Vitro Anticancer Activity of AIEgens.

Recent advances in AIE-based platforms for cancer immunotherapy

Exploration of Biocompatible AIEgens from Natural Resources

Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Aggregation-induced Emission Luminogen for Specific Identification of Malignant Tumour in Vivo

Cellular organelle-targeted smart AIEgens in tumor detection, imaging and therapeutics

Visualizing intracellular dynamics with AIE probes

On-chip selective capture of cancer cells and ultrasensitive fluorescence detection of survivin mRNA in a single living cell.

Fabricated AIE-Based Probe to Detect the Resistance to Anoikis of Cancer Cells Detached from Tumor Tissue

Quantification of Cell Viability and Rapid Screening Anti-Cancer Drug Utilizing Nanomechanical Fluctuation.

ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA